|
⚲
|
| Keyboard |
| Kamal Fariborz
✚
|
|
|---|---|
| CIK # | 0001834020 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001834020] | |
| 4 | [0001834020] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| 4D Molecular Therapeutics Inc | |
| Kamal Fariborz |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
|
2025-03-06 | Grant | 178,400 | $0.00 | |
|
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
|
2023-12-11 | Grant | 260,000 | $0.00 | |
|
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
|
2023-02-10 | Grant | 75,000 | $0.00 | |
|
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
|
2022-09-23 | Grant | 15,000 | $0.00 | |
|
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
|
2022-09-01 | Grant | 60,000 | $0.00 | |
|
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
|
2022-02-01 | Grant | 70,000 | $0.00 | |
|
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
|
2021-03-08 | Grant | 60,000 | $0.00 | |
|
4D Molecular Therapeutics Inc FDMT
Common Stock
|
2020-12-15 | Buy | 4,347 | $23.00 | 99,981 |